167 related articles for article (PubMed ID: 16679481)
21. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptors in canine mammary gland tumours.
Sobczak-Filipiak M; Malicka E
Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
[TBL] [Abstract][Full Text] [Related]
23. Expression of stratified squamous epithelia-type cytokeratin by canine mammary epithelial cells during tumorigenesis: type I (acidic) 57 kilodalton cytokeratin could be a molecular marker for malignant transformation of mammary epithelial cells.
Arai K; Kaneko S; Naoi M; Suzuki K; Maruo K; Uehara K
J Vet Med Sci; 1994 Feb; 56(1):51-8. PubMed ID: 7515697
[TBL] [Abstract][Full Text] [Related]
24. Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland.
Yoshimura H; Nakahira R; Kishimoto TE; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2014 Nov; 51(6):1090-5. PubMed ID: 24448671
[TBL] [Abstract][Full Text] [Related]
25. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
28. Can the One-Step Nucleic Acid Amplification method of lymph nodes examination make the staging of pulmonary tumours more precise?
Vodička J; Vejvodová Š; Pešta M; Mukenšnabl P; Špidlen V; Kulda V; Houfková K; Topolčan O
Rozhl Chir; 2018; 97(8):373-378. PubMed ID: 30441990
[TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
30. DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS.
Pereira MA; Ramos MFKP; Dias AR; Yagi OK; Faraj SF; Zilberstein B; Cecconello I; Mello ES; Ribeiro U
Arq Bras Cir Dig; 2017; 30(1):30-34. PubMed ID: 28489165
[TBL] [Abstract][Full Text] [Related]
31. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
Jeffers MD; O'Dowd GM; Mulcahy H; Stagg M; O'Donoghue DP; Toner M
J Pathol; 1994 Feb; 172(2):183-7. PubMed ID: 7513353
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
34. Nuclear morphometry in relation to lymph node status in canine mammary carcinomas.
De Vico G; Maiolino P; Cataldi M; Mazzullo G; Restucci B
Vet Res Commun; 2007 Nov; 31(8):1005-11. PubMed ID: 17279466
[TBL] [Abstract][Full Text] [Related]
35. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
36. Rapid multiple immunofluorescent staining for the simultaneous detection of cytokeratin and vimentin in the cytology of canine tumors.
Sawa M; Yabuki A; Kohyama M; Miyoshi N; Yamato O
Vet Clin Pathol; 2018 Jun; 47(2):326-332. PubMed ID: 29522252
[TBL] [Abstract][Full Text] [Related]
37. The accuracy of cytology in diagnosis and DNA analysis of canine mammary tumours.
Hellmén E; Lindgren A
J Comp Pathol; 1989 Nov; 101(4):443-50. PubMed ID: 2607016
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
39. Mammary lipid-rich carcinoma with extensive amyloid deposition in a dog.
Tei M; Uchida K; Chambers JK; Harada H; Takahashi M; Nishimura R; Watanabe M; Nakayama H
J Vet Med Sci; 2012 Jun; 74(6):809-11. PubMed ID: 22261147
[TBL] [Abstract][Full Text] [Related]
40. Expression of beta 1 integrin in normal, dysplastic and neoplastic canine mammary gland.
Restucci B; De Vico G; Maiolino P
J Comp Pathol; 1995 Aug; 113(2):165-73. PubMed ID: 8543673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
